Kestra Investment Management LLC Has $561,000 Holdings in Chemed Co. (NYSE:CHE)

Kestra Investment Management LLC raised its stake in Chemed Co. (NYSE:CHE) by 6.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,060 shares of the company’s stock after acquiring an additional 62 shares during the quarter. Kestra Investment Management LLC’s holdings in Chemed were worth $561,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Venturi Wealth Management LLC grew its position in shares of Chemed by 82.6% during the 4th quarter. Venturi Wealth Management LLC now owns 776 shares of the company’s stock worth $411,000 after buying an additional 351 shares during the period. CIBC Asset Management Inc grew its position in shares of Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after buying an additional 22 shares during the period. AlphaCentric Advisors LLC acquired a new stake in shares of Chemed during the 4th quarter worth approximately $520,000. Principal Financial Group Inc. grew its position in shares of Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company’s stock worth $39,554,000 after buying an additional 39,791 shares during the period. Finally, Allworth Financial LP grew its position in shares of Chemed by 2,057.1% during the 4th quarter. Allworth Financial LP now owns 151 shares of the company’s stock worth $83,000 after buying an additional 144 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada lowered their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Brian C. Judkins purchased 145 shares of Chemed stock in a transaction dated Monday, December 30th. The stock was bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares of the company’s stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Performance

Shares of NYSE CHE opened at $549.97 on Wednesday. The stock has a market cap of $8.28 billion, a P/E ratio of 27.79, a P/E/G ratio of 2.16 and a beta of 0.48. The firm has a 50 day moving average price of $542.45 and a 200 day moving average price of $564.40. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date is Monday, February 24th. Chemed’s dividend payout ratio is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.